| Date Filed | Type | Description |
| 08/09/2016 |
8-K
| Quarterly results |
| 08/04/2016 |
8-K
| Form 8-K - Current report |
| 08/03/2016 |
8-K
| Form 8-K - Current report |
| 05/26/2016 |
8-K
| Form 8-K - Current report |
| 05/13/2016 |
8-K
| Investor presentation |
| 05/04/2016 |
8-K
| Form 8-K - Current report |
| 04/06/2016 |
8-K
| Form 8-K - Current report |
| 03/30/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/22/2016 |
8-K
| Form 8-K - Current report |
| 03/16/2016 |
8-K
| Form 8-K - Current report |
| 03/01/2016 |
8-K
| Form 8-K - Current report |
| 02/12/2016 |
8-K
| Form 8-K - Current report |
| 01/13/2016 |
8-K
| Investor presentation |
| 12/02/2015 |
8-K
| Investor presentation |
| 11/13/2015 |
8-K
| Investor presentation |
| 10/23/2015 |
8-K
| Other Events |
| 08/14/2015 |
8-K
| Investor presentation |
| 08/10/2015 |
8-K
| Other Events |
| 08/05/2010 |
8-K
| Form 8-K - Current report |
| 07/27/2010 |
8-K
| Form 8-K - Current report |
| 07/21/2010 |
8-K
| Form 8-K - Current report |
| 07/06/2010 |
8-K
| Form 8-K - Current report |
| 06/09/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/01/2010 |
8-K
| Form 8-K - Current report |
| 05/27/2010 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 05/11/2010 |
8-K
| Form 8-K - Current report |
| 05/07/2010 |
8-K
| Form 8-K - Current report |
| 05/06/2010 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"inVentiv Health to be Acquired by Thomas H. Lee Partners SOMERSET, N.J., May 6, 2010 — inVentiv Health, Inc. , a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries, today announced that it has entered into a definitive agreement to be acquired by Thomas H. Lee Partners, L.P. , a leading private equity firm, for approximately $1.1 billion. Under the terms of the agreement, which has been approved by inVentiv's board of directors, inVentiv shareholders will receive $26.00 in cash for each share of VTIV common stock they hold, representing a 52% premium over the $17.15 closing stock price on March 25, 2010, the day before inVentiv announced that it had been approached by financial investors regardin..." |
|
| 05/06/2010 |
8-K
| Form 8-K - Current report |
| 03/19/2010 |
8-K
| Form 8-K - Current report |
| 02/24/2010 |
8-K
| Form 8-K - Current report |
| 12/16/2009 |
8-K
| Form 8-K - Current report |
| 11/05/2009 |
8-K
| Form 8-K - Current report |
| 08/06/2009 |
8-K
| Form 8-K - Current report |
|